Losartan, an angiotensin type 1 receptor antagonist, improves conduit vessel endothelial function in Type II diabetes

C. Cheetham, Gerry O'Driscoll, K. Stanton, R. Taylor, Daniel Green

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)
Original languageEnglish
Pages (from-to)13-17
JournalClinical Science
Volume100
Publication statusPublished - 2001

Cite this